Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomised phase III trial

<$O_ST_ABS>Background<$C_ST_ABS>The discussion on the role of adjuvant chemotherapy for rectal cancer patients treated according to current guidelines is still ongoing. A multicentre, randomised phase III trial, PROCTOR-SCRIPT, was conducted to compare adjuvant chemotherapy with observation for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision. <$O_ST_ABS>Patients and Methods<$C_ST_ABS>The PROCTOR-SCRIPT trial recruited patients from 52 hospitals. Patients with histologically proven stage II or III rectal adenocarcinoma w... Mehr ...

Verfasser: Breugom, A.J.
van Gijn, W.
Muller, E.W.
Berglund, Å.
van den Broek, C.B.M.
Fokstuen, T.
Gelderblom, H.
Kapiteijn, E.
Leer, J.W.H.
Marijnen, C.A.M.
Martijn, H.
Meershoek-Klein Kranenbarg, E.
Nagtegaal, I.D.
Påhlman, L.
Punt, C.J.A.
Putter, H.
Roodvoets, A.G.H.
Rutten, H.J.T.
Steup, W.H.
Glimelius, B.
van de Velde, C.J.H.
cooperative investigators of the Dutch Colorectal Cancer Group and the Nordic Gastrointestinal Tumour Adjuvant Therapy Group
Dokumenttyp: TEXT
Erscheinungsdatum: 2014
Verlag/Hrsg.: Oxford University Press
Schlagwörter: Original article
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26632031
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://annonc.oxfordjournals.org/cgi/content/short/mdu560v1